KY100001 / KPC Pharma 
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
KY100001 / KPC Pharma
NCT04906473: Safety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid Tumors

Not yet recruiting
1
109
NA
KY100001
Kunming Pharmaceuticals, Inc.
Advanced Solid Tumor
12/22
10/23

Download Options